6OR-5JZ9
General
Type : Sulfur Compound
Chemical_Nomenclature : 3,5-dichloro-4-hydroxybenzenesulfonic acid
Canonical SMILES : C1=C(C=C(C(=C1Cl)O)Cl)S(=O)(=O)O
InChI : InChI=1S\/C6H4Cl2O4S\/c7-4-1-3(13(10,11)12)2-5(8)6(4)9\/h1-2,9H,(H,10,11,12)
InChIKey : PGDCAFRJYQICAY-UHFFFAOYSA-N
Other name(s) : 3,5-Dichloro-4-hydroxybenzenesulphonic acid,3,5-Dichloro-4-Hydroxybenzene-1-Sulfonic Acid,ZINC1737176
MW : 243.06
Formula : C6H4Cl2O4S
CAS_number : 25319-98-6
PubChem : 91397
UniChem : PGDCAFRJYQICAY-UHFFFAOYSA-N
IUPHAR :
Wikipedia :
Target
Families : 6OR-5JZ9 ligand of proteins in family: Carbon-carbon_bond_hydrolase
Stucture : 5JZ9 Crystal structure of HsaD bound to 3,5-dichloro-4-hydroxybenzenesulphonic acid
Protein : myctu-Rv3569c
References (1)
| Title : Investigation of the mycobacterial enzyme HsaD as a potential novel target for anti-tubercular agents using a fragment-based drug design approach - Ryan_2017_Br.J.Pharmacol_174_2209 |
| Author(s) : Ryan A , Polycarpou E , Lack NA , Evangelopoulos D , Sieg C , Halman A , Bhakta S , Eleftheriadou O , McHugh TD , Keany S , Lowe ED , Ballet R , Abuhammad A , Jacobs WR, Jr. , Ciulli A , Sim E |
| Ref : British Journal of Pharmacology , 174 :2209 , 2017 |
| Abstract : Ryan_2017_Br.J.Pharmacol_174_2209 |
| ESTHER : Ryan_2017_Br.J.Pharmacol_174_2209 |
| PubMedSearch : Ryan_2017_Br.J.Pharmacol_174_2209 |
| PubMedID: 28380256 |
| Gene_locus related to this paper: myctu-Rv3569c |